Real-World Clinical Outcomes of Ujvira® (Trastuzumab Emtansine Biosimilar) in HER2-Positive Breast Cancer: A Retrospective Observational Study in Indian Patients. (2025). Journal of Cancer Research Updates, 14, 114-120. https://doi.org/10.30683/1929-2279.2025.14.13